ERY-TAB - 55289-217-40 - (Erythromycin)

Alphabetical Index


Drug Information of ERY-TAB

Product NDC: 55289-217
Proprietary Name: ERY-TAB
Non Proprietary Name: Erythromycin
Active Ingredient(s): 500    mg/1 & nbsp;   Erythromycin
Administration Route(s): ORAL
Dosage Form(s): TABLET, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of ERY-TAB

Product NDC: 55289-217
Labeler Name: PD-Rx Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA062298
Marketing Category: ANDA
Start Marketing Date: 20110418

Package Information of ERY-TAB

Package NDC: 55289-217-40
Package Description: 40 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-217-40)

NDC Information of ERY-TAB

NDC Code 55289-217-40
Proprietary Name ERY-TAB
Package Description 40 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-217-40)
Product NDC 55289-217
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Erythromycin
Dosage Form Name TABLET, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20110418
Marketing Category Name ANDA
Labeler Name PD-Rx Pharmaceuticals, Inc.
Substance Name ERYTHROMYCIN
Strength Number 500
Strength Unit mg/1
Pharmaceutical Classes Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient]

Complete Information of ERY-TAB


General Information